Displaying drugs 15226 - 15250 of 15594 in total
Undecyl-Phosphinic Acid Butyl Ester
Experimental
Benzylamine
Experimental
4-(Hydroxymethyl)Benzamidine
Experimental
Para-Bromobenzyl Alcohol
Experimental
DAS869
Experimental
Matched Iupac: … 1-tert-butyl-4-{6-methanesulfonyl-4'-methoxy-2-methyl-[1,1'-biphenyl]-3-carbonyl}-1H-pyrazol-5-ol …
4-Fluorobenzylamine
Experimental
2,6-Difluorobenzenesulfonamide
Experimental
4-(trifluoromethyl)phenol
Experimental
2-Iodobenzylthio Group
Experimental
N-phenylthiourea
Experimental
Coelenteramide
Experimental
Matched Iupac: … N-[3-benzyl-5-(4-hydroxyphenyl)pyrazin-2-yl]-2-(4-hydroxyphenyl)acetamide …
Balanol
Experimental
Matched Iupac: … 2-[2,6-dihydroxy-4-({[(3S,4R)-3-(4-hydroxybenzamido)azepan-4-yl]oxy}carbonyl)benzoyl]-3-hydroxybenzoic …
AL6528
Experimental
Matched Iupac: … 2-(3-methoxyphenyl)-1,1-dioxo-2H-1lambda6-thieno[3,2-e][1,2]thiazine-6-sulfonamide …
(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol
Experimental
Asimadoline
Asimadoline is a proprietary small molecule therapeutic, originally discovered by Merck KGaA of Darmstadt, Germany. Asimadoline was originally developed to treat peripheral pain such as arthritis. Asimadoline is an orally administered agent that acts as a kappa opioid receptor agonist. It has shown encouraging clinical efficacy for the treatment of...
Investigational
Matched Iupac: … N-[(1S)-2-[(3S)-3-hydroxypyrrolidin-1-yl]-1-phenylethyl]-N-methyl-2,2-diphenylacetamide …
Matched Description: … has shown encouraging clinical efficacy for the treatment of IBS in a barostat study in IBS patients and …
Matched Description: … has shown encouraging clinical efficacy for the treatment of IBS in a barostat study in IBS patients and …
Refametinib
Investigational
GW-590735
Investigational
5-(2-CHLORO-4-NITROPHENYL)-2-FUROIC ACID
Experimental
4-(METHYLSULFONYL)BENZENECARBOXIMIDAMIDE
Experimental
Displaying drugs 15226 - 15250 of 15594 in total